nach oben

Erschienen in:

01.04.2021 | Original Article

The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial

verfasst von: Angkana Sathaworawong, Woraphong Manuskiatti, Chayawat Phatihattakorn, Chanida Ungaksornpairote, Janice Natasha Ng

Erschienen in: Lasers in Medical Science | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Vaginal laxity, a common cause of decreased sexual sensation, is a common problem affecting the quality of life of women worldwide. Recently, lasers and energy-based devices (EBDs) have been applied in the treatment of this condition. The aim of this study was to compare the efficacy and safety of Er:YAG laser and placebo in treating decreased sexual sensation in Asians. Forty-two patients with decreased sexual sensation were randomized into 2 groups: intervention (laser treatment) and control (placebo treatment). Both groups received two treatments, at 1-month interval. Subjective and objective evaluations were done at baseline, 1-, 3-, and 6-month follow-ups. Pain score and adverse effects were also recorded. In the laser group, there was significant improvement in the patients’ vaginal tightness satisfaction at 1- and 3-month follow-ups (P = 0.002 and 0.004) and also in the patients’ overall satisfaction at 1- and 3-month follow-ups (P = 0.003 and 0.001). Pelvic floor muscle contraction was significantly better in the laser group after the first treatment (P = 0.043). No serious adverse effects were noted. Er:YAG laser provides improvement of sexual sensation for an average of 3 months following treatment. Mild and transient adverse effects such as leukorrhea, dryness, dysuria, vaginal itching, and spot bleeding were noted in the laser group, and these were not significantly different from the control group.

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A et al (2016) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 27(4):655–684. https://doi.org/10.1007/s00192-016-3003-y10.1007/s00192-016-3003-yCrossRefPubMed

Rogers GR, Villarreal A, Kammerer-Doak D, Qualls C (2001) Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 12(6):361–365CrossRef

Campbell P, Krychman M, Gray T, Vickers H, Money-Taylor J, Li W et al (2018) Self-reported vaginal laxity-prevalence, impact, and associated symptoms in women attending a urogynecology clinic. J Sex Med. 15(11):1515–1517. https://doi.org/10.1016/j.jsxm.2018.08.015CrossRefPubMed

Hacker NF, Gambone JG, Hobel CJ (2010) Hacker and Moor essentials of obstetrics and gynecology, 5th edn. Saunders, Philadelphia

Pauls RN, Fellner AN, Davila GW (2012) Vaginal laxity: a poorly understood quality of life problem; a survey of physician members of the International Urogynecological Association (IUGA). Int Urogynecol J. 23(10):1435–1448. https://doi.org/10.1007/s00192-012-1757-4CrossRefPubMed

Frawley HC, Galea MP, Phillips BA, Sherburn M, Bo K (2006) Reliability of pelvic floor muscle strength assessment using different test positions and tools. Neurourol Urodyn. 25(3):236–242. https://doi.org/10.1002/nau.20201CrossRefPubMed

Ashton-Miller JA, Zielinski R, DeLancey JO, Miller JM (2014) Validity and reliability of an instrumented speculum designed to minimize the effect of intra-abdominal pressure on the measurement of pelvic floor muscle strength. Clin Biomech (Bristol, Avon) 29(10):1146–1150. https://doi.org/10.1016/j.clinbiomech.2014.09.011S0268-0033(14)00223-XCrossRef

Marques A, Stothers L, Macnab A (2010) The status of pelvic floor muscle training for women. Can Urol Assoc J. 4(6):419–424CrossRef

Arvonen T, Fianu-Jonasson A, Tyni-Lenne R (2001) Effectiveness of two conservative modes of physical therapy in women with urinary stress incontinence. Neurourol Urodyn. 20(5):591–599. https://doi.org/10.1002/nau.1011CrossRefPubMed

10.

Vanaman M, Bolton J, Placik O, Fabi SG (2016) Emerging trends in nonsurgical female genital rejuvenation. Dermatol Surg. 42(9):1019–1029. https://doi.org/10.1097/DSS.0000000000000697CrossRefPubMed

11.

Kwon TR, Kim JH, Seok J, Kim JM, Bak DH, Choi MJ et al (2018) Fractional CO₂ laser treatment for vaginal laxity: a preclinical study. Lasers Surg Med. 50(9):940–947. https://doi.org/10.1002/lsm.22940CrossRefPubMed

12.

Lalji S, Lozanova P (2017) Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvo-vaginal laxity and urinary incontinence. J Cosmet Dermatol. 16(2):230–234. https://doi.org/10.1111/jocd.12348CrossRefPubMed

13.

Lang P, Karram M (2017) Lasers for pelvic floor dysfunctions: is there evidence? Curr Opin Obstet Gynecol. 29(5):354–358. https://doi.org/10.1097/GCO.0000000000000399CrossRefPubMed

14.

Krychman ML (2016) Vaginal laxity issues, answers and implications for female sexual function. J Sex Med. 13(10):1445–1447. https://doi.org/10.1016/j.jsxm.2016.07.016CrossRefPubMed

15.

Gambacciani M, Palacios S (2017) Laser therapy for the restoration of vaginal function. Maturitas 99:10–15. https://doi.org/10.1016/j.maturitas.2017.01.012CrossRefPubMed

16.

Vizintin Z, Lukac M, Kazic M, Tettamanti M (2015) Erbium laser in gynecology. Climacteric. 18(Suppl 1):4–8. https://doi.org/10.3109/13697137.2015.1078668CrossRefPubMed

17.

Portman DJ, Gass ML (2014) Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. Climacteric. 17(5):557–563. https://doi.org/10.3109/13697137.2014.946279CrossRefPubMed

18.

Farshidi D, Hovenic W, Zachary C (2014) Erbium:yttrium aluminum garnet ablative laser resurfacing for skin tightening. Dermatol Surg. 40(Suppl 12):S152–S156. https://doi.org/10.1097/DSS.000000000000022600042728-201412001-00007CrossRefPubMed

19.

Walsh JT Jr, Cummings JP (1994) Effect of the dynamic optical properties of water on midinfrared laser ablation. Lasers Surg Med. 15(3):295–305CrossRef

20.

Cetinkaya EA, Turker M, Kiraz K, Gulkesen HK (2016) Er:Yag laser treatment of simple snorers in an outpatient setting. ORL J Otorhinolaryngol Relat Spec. 78(2):70–76. https://doi.org/10.1159/000443510000443510 [pii]CrossRefPubMed

21.

Unver T, Aytugar E, Ozturan O, Kiran T, Ademci E, Usumez A (2016) Histological effects of Er:YAG laser irradiation with snoring handpiece in the rat soft palate. Photomed Laser Surg. 34(8):321–325. https://doi.org/10.1089/pho.2015.4044CrossRefPubMed

22.

Lee MS (2014) Treatment of vaginal relaxation syndrome with an Erbium:YAG laser using 90 degrees and 360 degrees scanning scopes: a pilot study & short-term results. Laser Ther. 23(2):129–138. https://doi.org/10.5978/islsm.14-OR-11CrossRefPubMedPubMedCentral

23.

Miranne JM, Marek TM, Mete M, Iglesia CB (2015) Prevalence and resolution of auditory passage of vaginal air in women with pelvic floor disorders. Obstet Gynecol. 126(1):136–143. https://doi.org/10.1097/AOG.0000000000000921CrossRefPubMed

24.

McCoy NL (2000) The McCoy female sexuality questionnaire. Quality of Life Research. 9:739–745CrossRef

25.

Rellini AH, Nappi RE, Vaccaro P, Ferdeghini F, Abbiati I, Meston CM (2005) Validation of the McCoy female sexuality questionnaire in an Italian sample. Arch Sex Behav. 34(6):641–647. https://doi.org/10.1007/s10508-005-7915-8CrossRefPubMed

26.

Gaviria JE, Lanz JA (2012) Vaginal tightening (LVT) – evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J Laser Heal Acad. 1:59–66

27.

Alinsod RM (2016) Transcutaneous temperature controlled radiofrequency for orgasmic dysfunction. Lasers Surg Med. 48(7):641–645. https://doi.org/10.1002/lsm.22537CrossRefPubMedPubMedCentral

28.

Magon N, Alinsod R (2016) ThermiVa: the revolutionary technology for vulvovaginal rejuvenation and noninvasive management of female SUI. J Obstet Gynaecol India. 66(4):300–302. https://doi.org/10.1007/s13224-016-0868-0CrossRefPubMedPubMedCentral

29.

Krychman M, Rowan CG, Allan BB, DeRogatis L, Durbin S, Yacoubian A et al (2017) Effect of single-treatment, surface-cooled radiofrequency therapy on vaginal laxity and female sexual function: the VIVEVE I randomized controlled trial. J Sex Med. 14(2):215–225. https://doi.org/10.1016/j.jsxm.2016.11.322CrossRefPubMed

30.

Alexiades M (2018) Device-based treatment for vaginal wellness. Semin Cutan Med Surg 37(4):226–232. https://doi.org/10.12788/j.sder.2018.052CrossRefPubMed

31.

Schanz J, Dalenz V, Almiron I (2018) Treatment of female stress urinary incontinence with hybrid fractional laser, preliminary study. J Gynecol Women’s Health. 11(3):555815

32.

Gold M, Andriessen A, Bader A, Alinsod R, French ES, Guerette N et al (2018) Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation. J Cosmet Dermatol. 17(3):289–297. https://doi.org/10.1111/jocd.12524CrossRefPubMed

33.

Gaspar A, Addamo G, Brandi H (2011) Vaginal fractional CO₂ laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg. 28:156–162CrossRef

34.

Mitsuyuki M, Stok U, Hreljac I, Yoda K, Vizintin Z (2020) Treating vaginal laxity using nonablative Er:YAG laser: a retrospective case series of patients from 2.5 years of clinical practice. Sex Med. 8(2):265–273. https://doi.org/10.1016/j.esxm.2020.01.001CrossRefPubMedPubMedCentral

35.

Gaspar A, Brandi H, Gomez V, Luque D (2017) Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. 49(2):160–168. https://doi.org/10.1002/lsm.22569CrossRefPubMed

36.

Fistonic N, Fistonic I, Gustek SF, Turina IS, Marton I, Vizintin Z et al (2016) Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women–a pilot study. Lasers Med Sci. 31(4):635–643. https://doi.org/10.1007/s10103-016-1884-010.1007/s10103-016-1884-0CrossRefPubMedPubMedCentral

37.

Manuskiatti W, Punyaratabandhu P, Tantrapornpong P, Yan C, Cembrano KAG (2020) Objective and long-term evaluation of the efficacy and safety of a 1064-nm picosecond laser with fractionated microlens array for the treatment of atrophic acne scar in Asians. Lasers Surg Med. https://doi.org/10.1002/lsm.23368

38.

Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphakdeedecha R (2010) Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol. 63(2):274–283. https://doi.org/10.1016/j.jaad.2009.08.051CrossRefPubMed

39.

Al-Badr A, Alkhamis WH (2019) Laser vaginal tightening complications: report of three cases. Lasers Surg Med. 51(9):757–759. https://doi.org/10.1002/lsm.23110CrossRefPubMedPubMedCentral

40.

Administration USFD (2018) FDA warns against use of energy-based devices to perform vaginal ‘rejuvenation’ or vaginal cosmetic procedures: FDA safety communication. https://www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic. Accessed 13th February 2021.

41.

Okui N (2019) Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol. 37(5):885–889. https://doi.org/10.1007/s00345-018-2445-xCrossRefPubMed

42.

Blaganje M, Scepanovic D, Zgur L, Verdenik I, Pajk F, Lukanovic A (2018) Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 224:153–158. https://doi.org/10.1016/j.ejogrb.2018.03.038CrossRefPubMed

Titel: The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial
verfasst von: Angkana Sathaworawong
Woraphong Manuskiatti
Chayawat Phatihattakorn
Chanida Ungaksornpairote
Janice Natasha Ng
Publikationsdatum: 01.04.2021
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 1/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03305-1

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Mechanistic aspects of photobiomodulation therapy in the nervous system

Photobiomodulation enhances the Th1 immune response of human monocytes

Erbium lasers in non-surgical periodontal therapy: an umbrella review and evidence gap map analysis

Effects of laser acupuncture tele-therapy for rheumatoid arthritis elderly patients

The effect of Q-switched 1064-nm dymium-doped yttrium aluminum garnet laser on the skin barrier and collagen synthesis through miR-24-3p

Laser treatment of umbilical pilonidal sinus